FREQUENCY THERAPEUTICS INC (FREQ) Stock Analyst Ratings
USA - NASDAQ:FREQ - US35803L1089 - Common Stock
0.2996 USD
+0.02 (+5.94%)
ChartMill assigns a Buy % Consensus number of 43% to FREQ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.51. This target is 70.23% above the current price.
FREQ was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about FREQ.
In the previous month the buy percentage consensus was at a similar level.
FREQ was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-26 | Baird | Downgrade | Outperform -> Neutral |
| 2023-02-15 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2023-02-14 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-02-14 | Baird | Maintains | Outperform |
| 2022-12-08 | Chardan Capital | Initiate | Buy |
| 2022-11-02 | Baird | Initiate | Outperform |
| 2022-05-24 | Goldman Sachs | Maintains | Neutral |
| 2021-09-22 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2021-03-24 | Oppenheimer | Maintains | Outperform |
FREQUENCY THERAPEUTICS INC / FREQ FAQ
What is the average price target for FREQUENCY THERAPEUTICS INC (FREQ) stock?
6 analysts have analysed FREQ and the average price target is 0.51 USD. This implies a price increase of 70.23% is expected in the next year compared to the current price of 0.2996.
How do analysts rate FREQUENCY THERAPEUTICS INC (FREQ)?
The consensus rating for FREQUENCY THERAPEUTICS INC (FREQ) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.